These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18368760)

  • 1. [Use of continuous human and animal cell lines for the production of viral vaccines].
    Grachev VP; Khapchaev IuKh
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (1):82-90. PubMed ID: 18368760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines.
    Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H
    Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.
    Merten OW
    Dev Biol (Basel); 2002; 111():233-57. PubMed ID: 12678248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends in cell substrate considerations for continuous cell lines.
    Lubiniecki AS; Petricciani JC
    Curr Opin Biotechnol; 2001 Jun; 12(3):317-9. PubMed ID: 11404113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal characterization of MRC-5 cell banks utilizing G-banding technique.
    Rosolowsky M; McKee R; Nichols W; Garfinkle B
    Dev Biol Stand; 1998; 93():109-17. PubMed ID: 9737385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possibilities of vaccine manufacture in human diploid cell strains with a serum replacement factor.
    Candal FJ; George VG; Ades EW
    Biologicals; 1991 Jul; 19(3):213-8. PubMed ID: 1659430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines produced in diploid cell lines--discussion.
    Perkins FT
    Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccine production: upstream processing with adherent or suspension cell lines.
    Genzel Y; Rödig J; Rapp E; Reichl U
    Methods Mol Biol; 2014; 1104():371-93. PubMed ID: 24297427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [M-29 human diploid cells line--a substrate for the production of antiviral vaccines].
    Borisova TK; Zverev VV; Mironova LL; Koniushko OI; Zabiiaka IuI; Shukhmina NR; Vashchenko VI
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (3):43-8. PubMed ID: 21809644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Further studies of continuous human and animal cell lines for the manufacture of viral vaccines and diagnostic kits].
    Mironova LL; Koniushko OI; Popova VD
    Vopr Virusol; 2005; 50(3):56-60. PubMed ID: 16078436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perfusion culture system for virus vaccine manufacture in diploid cell cultures.
    Mann GF; de Mucha Macías J
    Bull Pan Am Health Organ; 1976; 10(3):205-11. PubMed ID: 187274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of vaccines with special reference to rubella vaccine RA 27-3 strain in WI 38 cells.
    Beale AJ
    Adv Exp Med Biol; 1972; 31(0):179-86. PubMed ID: 4671959
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification standards of primary cultures and diploid cell lines--discussion.
    Stulberg CS
    Natl Cancer Inst Monogr; 1968 Dec; 29():15-9. PubMed ID: 5720789
    [No Abstract]   [Full Text] [Related]  

  • 14. Technology of production of primary and diploid cell cultures.
    Brackett RG
    Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.
    Wu SC; Liu CC; Lian WC
    Vaccine; 2004 Sep; 22(29-30):3858-64. PubMed ID: 15364432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract]   [Full Text] [Related]  

  • 17. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus screening of vaccine cell substrates.
    Khan AS
    Dev Biol Stand; 1996; 88():157-62. PubMed ID: 9119131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.
    Barrett PN; Mundt W; Kistner O; Howard MK
    Expert Rev Vaccines; 2009 May; 8(5):607-18. PubMed ID: 19397417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
    Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
    Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.